• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉萎缩症的基因修饰因子:对治疗的意义。

Genetic modifiers of muscular dystrophy: implications for therapy.

作者信息

Heydemann Ahlke, Doherty Katherine R, McNally Elizabeth M

机构信息

Department of Medicine, Section of Cardiology, The University of Chicago, Chicago, IL 60637, USA.

出版信息

Biochim Biophys Acta. 2007 Feb;1772(2):216-28. doi: 10.1016/j.bbadis.2006.06.013. Epub 2006 Jul 11.

DOI:10.1016/j.bbadis.2006.06.013
PMID:16916601
Abstract

The genetic understanding of the muscular dystrophies has advanced considerably in the last two decades. Over 25 different individual genes are now known to produce muscular dystrophy, and many different "private" mutations have been described for each individual muscular dystrophy gene. For the more common forms of muscular dystrophy, phenotypic variability can be explained by precise mutations. However, for many genetic mutations, the presence of the identical mutation is associated with marked phenotypic range that affects muscle function as well as cardiac function. The explanation for phenotype variability in the muscular dystrophies is only now being explored. The availability of genetically engineered animal models has allowed the generation of single mutations on the background of highly inbred strain. Phenotypic variation that is altered by genetic background argues for the presence of genetic modifier loci that can ameliorate or enhance aspects of the dystrophic phenotype. A number of individual genes have been implicated as modifiers of muscular dystrophy by studies in genetically engineered mouse models of muscular dystrophy. The value of these genes and products is that the pathways identified through these experiments may be exploited for therapy.

摘要

在过去二十年里,对肌营养不良症的遗传学认识有了显著进展。目前已知超过25种不同的个体基因会导致肌营养不良症,并且针对每个个体的肌营养不良症基因都描述了许多不同的“私人”突变。对于更常见的肌营养不良症形式,表型变异性可以通过精确的突变来解释。然而,对于许多基因突变,相同突变的存在与显著的表型范围相关,这会影响肌肉功能以及心脏功能。目前才开始探索肌营养不良症中表型变异性的解释。基因工程动物模型的可用性使得能够在高度近交系的背景下产生单一突变。由遗传背景改变的表型变异表明存在可以改善或增强营养不良表型各方面的遗传修饰位点。通过对基因工程肌营养不良小鼠模型的研究,一些个体基因已被认为是肌营养不良症的修饰基因。这些基因和产物的价值在于,通过这些实验确定的途径可能被用于治疗。

相似文献

1
Genetic modifiers of muscular dystrophy: implications for therapy.肌肉萎缩症的基因修饰因子:对治疗的意义。
Biochim Biophys Acta. 2007 Feb;1772(2):216-28. doi: 10.1016/j.bbadis.2006.06.013. Epub 2006 Jul 11.
2
Genetic background influences muscular dystrophy.遗传背景会影响肌肉萎缩症。
Neuromuscul Disord. 2005 Oct;15(9-10):601-9. doi: 10.1016/j.nmd.2005.05.004.
3
The muscular dystrophies.肌营养不良症
Baillieres Clin Neurol. 1994 Aug;3(2):407-30.
4
Muscle diseases: the muscular dystrophies.肌肉疾病:肌营养不良症
Annu Rev Pathol. 2007;2:87-109. doi: 10.1146/annurev.pathol.2.010506.091936.
5
[The genetic basis of muscle disease].[肌肉疾病的遗传基础]
Tidsskr Nor Laegeforen. 2003 Sep 25;123(18):2588-92.
6
Dysferlin and muscular dystrophy.肌膜蛋白与肌肉萎缩症
Acta Neurol Belg. 2000 Sep;100(3):142-5.
7
Gene therapy for muscular dystrophy: moving the field forward.用于治疗肌肉萎缩症的基因疗法:推动该领域向前发展。
Pediatr Neurol. 2014 Nov;51(5):607-18. doi: 10.1016/j.pediatrneurol.2014.08.002. Epub 2014 Aug 7.
8
Genetic defects in muscular dystrophy.肌肉萎缩症中的基因缺陷。
Methods Enzymol. 2010;479:291-322. doi: 10.1016/S0076-6879(10)79017-0.
9
Outside in: The matrix as a modifier of muscular dystrophy.从外向内:基质作为肌肉萎缩症的修饰物。
Biochim Biophys Acta Mol Cell Res. 2017 Mar;1864(3):572-579. doi: 10.1016/j.bbamcr.2016.12.020. Epub 2016 Dec 21.
10
Muscular dystrophy: from pathogenesis to strategy.肌肉萎缩症:从发病机制到应对策略
Acta Neurol Taiwan. 2004 Jun;13(2):50-8.

引用本文的文献

1
Two distinct phenotypes and a novel mutation in limb-girdle muscular dystrophy R7 telethonin-related patients from Thai neuromuscular center.来自泰国神经肌肉中心的与肢带型肌营养不良症R7肌联蛋白相关患者中的两种不同表型和一种新突变。
Neurol Sci. 2025 Apr 7. doi: 10.1007/s10072-025-08158-y.
2
Exploring Splice-Site Mutations in LAMA2-Related Muscular Dystrophies: A Comprehensive Analysis of Genotypic and Phenotypic Patterns.探索与LAMA2相关的肌营养不良症中的剪接位点突变:基因型和表型模式的综合分析
Cureus. 2024 Jun 3;16(6):e61599. doi: 10.7759/cureus.61599. eCollection 2024 Jun.
3
System-level analysis of genes mutated in muscular dystrophies reveals a functional pattern associated with muscle weakness distribution.
肌肉疾病中突变基因的系统水平分析揭示了与肌肉无力分布相关的功能模式。
Sci Rep. 2024 May 16;14(1):11225. doi: 10.1038/s41598-024-60761-9.
4
Genotype-Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry.来自加拿大神经肌肉疾病登记处的杜氏和贝克型肌营养不良症患者的基因型-表型相关性
J Pers Med. 2020 Nov 23;10(4):241. doi: 10.3390/jpm10040241.
5
Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.杜兴氏和贝克氏肌营养不良症:动物模型、临床终点及生物标志物定量综述
Toxicol Pathol. 2017 Oct;45(7):961-976. doi: 10.1177/0192623317734823. Epub 2017 Oct 3.
6
Genetic doping and health damages.基因兴奋剂与健康损害。
Iran J Public Health. 2011;40(1):1-14. Epub 2011 Mar 31.
7
Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2.患有LAMA2基因c.3924 + 2 T > C突变的沙特阿拉伯和苏丹家庭中疾病严重程度的差异
BMC Res Notes. 2011 Dec 13;4:534. doi: 10.1186/1756-0500-4-534.
8
Duchenne muscular dystrophy gene therapy: Lost in translation?杜兴氏肌营养不良症基因治疗:翻译之失?
Res Rep Biol. 2011 Mar;2011(2):31-42. doi: 10.2147/RRB.S13463.
9
An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed.肌营养不良蛋白基因中的内含子 LINE-1 元件插入会使肌营养不良蛋白表达中止,并导致柯基犬种出现类似于杜氏肌营养不良症的肌肉疾病。
Lab Invest. 2011 Feb;91(2):216-31. doi: 10.1038/labinvest.2010.146. Epub 2010 Aug 16.
10
Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.肌膜 nNOS 锚定揭示了 dystrophin 和 utrophin 之间的定性差异。
J Cell Sci. 2010 Jun 15;123(Pt 12):2008-13. doi: 10.1242/jcs.064808. Epub 2010 May 18.